The role of probiotics in managing premenstrual syndrome: insights into beneficial bacterial strains

Simple item page
dc.contributor.authorPriyadharshini, Ren_US
dc.contributor.authorSubhashini, R.en_US
dc.date.accessioned2025-06-18T11:23:11Z
dc.date.available2025-06-18T11:23:11Z
dc.date.issued2025-06
dc.description.abstractPremenstrual disorders (PMDs), encompassing premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD), affect a significant number of women globally. Despite various hypothesized causes like hormonal shifts, serotonin imbalances, and lifestyle factors, the precise etiology remains unclear. Recent research emphasizes the crucial role of the gut microbiota in influencing mental and physical health, particularly through the gut-brain axis, which facilitates neuroendocrine communication. The gut microbiome's impact on endocrine, metabolic, and immune systems is significant, linking variations in gut microbiota diversity to conditions such as major depressive disorder (MDD) and metabolic disorders. Probiotics, known for modulating gut microbiota, show promise in managing PMDs and primary dysmenorrhea by influencing microbial diversity, metabolite profiles, and inflammatory pathways. Studies indicate that certain probiotic strains regulate cytokine production, enhance immunological tolerance, and may alleviate symptoms of hormone-related disorders. Traditional treatments for primary dysmenorrhea, including NSAIDs and hormonal therapy, often have adverse effects and limited efficacy, making probiotics a safer and potentially more effective alternative. Further research is essential to fully understand the molecular mechanisms of probiotics. However, current evidence suggests they could significantly improve women's reproductive health, reduce premenstrual symptoms, and offer a novel approach to managing primary dysmenorrhea, thereby enhancing the quality of life for affected women.en_US
dc.identifier.affiliationsSwamy Vivekananda College of Pharmacy, Namakkal, Tamil Nadu, Indiaen_US
dc.identifier.affiliationsSwamy Vivekananda College of Pharmacy, Namakkal, Tamil Nadu, Indiaen_US
dc.identifier.citationPriyadharshini R, Subhashini R.. The role of probiotics in managing premenstrual syndrome: insights into beneficial bacterial strains. International Journal of Basic & Clinical Pharmacology. 2025 Jun; 14(3): 418-422en_US
dc.identifier.issn2319-2003
dc.identifier.issn2279-0780
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/248647
dc.languageenen_US
dc.publisherMedip Academyen_US
dc.relation.issuenumber3en_US
dc.relation.volume14en_US
dc.source.urihttps://doi.org/10.18203/2319-2003.ijbcp20251070en_US
dc.subjectPremenstrual disordersen_US
dc.subjectGut microbiotaen_US
dc.subjectGut-brain axisen_US
dc.subjectProbioticsen_US
dc.subjectCytokine productionen_US
dc.subjectImmune modulationen_US
dc.subjectHormone-related disordersen_US
dc.titleThe role of probiotics in managing premenstrual syndrome: insights into beneficial bacterial strainsen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ijbcp2025v14n3p418.pdf
Size:
185.09 KB
Format:
Adobe Portable Document Format
Download
Collections
International Journal of Basic & Clinical Pharmacology